Author + information
- Christopher O'Connor, MD, FACC, Editor-in-Chief, JACC: Heart Failure∗ ()
- ↵∗Address for correspondence:
Christopher O'Connor, MD, FACC, JACC: Heart Failure, 3655 Nobel Drive, Suite 630, San Diego, California 92122
Heart failure continues to be one of the most important conditions in cardiology today. The burden of heart failure in this country alone is associated with 1 million hospitalizations and an annual mortality rate of 10%. Over 5 million Americans are affected by this chronic condition. In addition, it is associated with a tremendous cost to the healthcare system with billions of healthcare dollars spent annually, and is the number one reason for admission to the hospital in the Medicare population. We believe, with the improvements in survival in cardiovascular conditions, the nonfatal burden of heart failure will continue to increase in this country and globally, and present an increasing challenge for healthcare providers in all aspects of practice, whether it is primary care or advanced cardiology. Given this increase in burden of disease, there is a significant opportunity for the development of a premier journal and method of communication of information that will help with the understanding, prevention, diagnosis, and treatment of heart failure. JACC: Heart Failure and its editorial leadership will work together with clinicians and scientists to reduce the burden of this condition and improve outcomes through important and timely scientific communication.
First, we believe by building a team of scholars, we will encourage and enhance the reporting of information and knowledge in a timely fashion that is of the highest quality, which will result in the improvement of human health. Second, by establishing a global presence, in which new knowledge is being developed about heart failure, the journal will quickly become a popular method of communication in this field. In addition, we will develop a strong culture of mentoring and developing younger generations of investigators; not only by disseminating information through the journal, but also as editorial scholars. This novel program will enlist and solicit the brightest minds in the cardiovascular field of heart failure to spend dedicated time working with the journal and understanding the goals, missions, and objectives of medical communication in this field. Finally, by being an integral member of the JACC journal family, we will work together with the other JACC publications to enhance the group from the American College of Cardiology.
We are truly excited about the potential opportunity of JACC: Heart Failure to enhance the field of medical communication in this chronic disease condition.
In this inaugural issue, we are honored to include a state-of-the-condition update by Dr. Eugene Braunwald, someone who has witnessed the many advances and challenges over the past 5 decades. The scientific papers in this issue reflect the high quality and breadth of international investigation in the field. These papers exemplify the journal’s aims to publish the full range of topics related to this condition, including basic and translational science, trials and registries, comorbidities, biomarkers, advanced heart failure, and outcomes. We hope that you enjoy this premier issue, and look forward to more important science to come.
- American College of Cardiology Foundation